Cochlear, WiseTech, DroneShield, Westpac: What Happened to Key ASX Stocks in May

The Quick Take

• Cochlear shares crashed 62% in 2026 after a massive earnings downgrade, with May continuing the stock's difficult recovery path.
• WiseTech Global fell 47% year to date and 66% in 12 months as logistics software sector faces growth deceleration concerns.
• Westpac fell 6.5% in May amid a court ruling and going ex-dividend, while DroneShield remained volatile in the defence technology sector.

May was a challenging month for several high-profile ASX constituents. Cochlear's ongoing decline following a devastating earnings downgrade reflects the market's harsh re-rating of high-multiple healthcare stocks when growth thesis breaks down — from over 40x earnings to current depressed levels, the stock illustrates the downside of premium valuation concentration risk. WiseTech Global's 47% year-to-date decline combines founder governance concerns with a broader global logistics software re-rating, as post-pandemic supply chain normalisation reduced the urgency premium investors had assigned to logistics technology providers.

The breadth of May weakness across sector diverse ASX names — from medtech to logistics software, defence technology, and banking — reflects a combination of stock-specific factors and macro headwinds. Westpac's 6.5% monthly decline was compounded by ex-dividend timing and an adverse court ruling, both of which are quantifiable one-off factors that may not persist. DroneShield's volatility is characteristic of small-cap defence technology stocks where contract announcements or delays create outsized price moves. Australian investors with concentrated ASX exposure are navigating a period where domestic high-growth stocks have underperformed US AI-sector comparables.

The forward signal for Cochlear is its next quarterly update and any guidance revision — after a 62% decline, the stock trades at a level where a stabilised earnings outlook could attract value-oriented fund managers. For WiseTech, resolution of the governance overhang created by founder Richard White's position is the key catalyst that could re-engage institutional investors. Westpac's trajectory depends on the broader Australian housing and credit cycle, which the RBA's rate decisions will heavily influence. The macro variable is Australian GDP growth and consumer confidence — any deterioration accelerates potential earnings downgrades across domestic consumption-linked sectors.

Synthesized from 4 sources.